Zdrowie i gospodarka · 28/12/2023
FDA Releases Draft Guidance on Potency Assurance for Cellular and Gene Therapy Products
The FDA is releasing a draft guidance to provide recommendations for ensuring the potency of human cellular therapy and gene therapy products throughout their lifecycle, covering product development and licensed products.
Source: Federal Register — Food and Drug AdministrationOpen original release →